{"disease":{"id":"advanced-triple-negative-breast-cancer-tnbc-with-high-tams","name":"advanced triple negative breast cancer tnbc with high tams"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02435680","title":"Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}